| scholarly article | Q13442814 |
| P50 | author | Michael A. Piradov | Q4363243 |
| Simon Iain Hay | Q15994492 | ||
| Ferrán Catalá-López | Q28606975 | ||
| Sadaf G. Sepanlou | Q37606621 | ||
| David M. Pereira | Q37607476 | ||
| Maysaa El Sayed Zaki | Q37607512 | ||
| Mostafa Qorbani | Q47502687 | ||
| Alireza Mohammadi | Q52313551 | ||
| Tesfay Mehari Atey | Q56428231 | ||
| Morteza Shamsizadeh | Q59591758 | ||
| Benn Sartorius | Q64952391 | ||
| P2093 | author name string | GBD 2015 Neurological Disorders Collaborator Group | |
| P2860 | cites work | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q21534928 |
| Epidemiologic evidence for multiple sclerosis as an infection | Q24615844 | ||
| Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement | Q26745512 | ||
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. | Q26782024 | ||
| Epidemiology of Japanese encephalitis in the Philippines: a systematic review | Q27304581 | ||
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 | Q27468570 | ||
| Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review | Q28069707 | ||
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 | Q28083357 | ||
| GBD 2010: design, definitions, and metrics | Q28281570 | ||
| Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. | Q28597175 | ||
| Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30061930 | ||
| Tick-borne encephalitis in China: A review of epidemiology and vaccines | Q30236032 | ||
| Sex differences in the epidemiology, clinical features, and pathophysiology of migraine | Q30241432 | ||
| Prevention of stroke: a strategic global imperative | Q30248840 | ||
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353189 | ||
| The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis | Q30382505 | ||
| Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature | Q30580165 | ||
| Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography | Q34287687 | ||
| Has the prevalence of migraine changed over the last decade (2003-2012)? A Spanish population-based survey. | Q34400544 | ||
| The global burden of headache: a documentation of headache prevalence and disability worldwide | Q34611721 | ||
| Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets | Q35178959 | ||
| Incidence of epilepsy: a systematic review and meta-analysis. | Q35210256 | ||
| Modeling causes of death: an integrated approach using CODEm | Q35860880 | ||
| Epidemiology and aetiology of epilepsy in sub-Saharan Africa | Q35994383 | ||
| Estimation of the burden of active and life-time epilepsy: a meta-analytic approach | Q36135562 | ||
| Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades. | Q36311261 | ||
| Trends in blood pressure and hypertension detection, treatment, and control 1980 to 2009: the Minnesota Heart Survey | Q36352814 | ||
| Epidemiology and natural history of multiple sclerosis: new insights | Q36479921 | ||
| A review of the epidemiology, pathogenesis and management of tetanus | Q36802791 | ||
| Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues | Q37031806 | ||
| Recent global trends in the prevalence and incidence of dementia, and survival with dementia | Q37139880 | ||
| The descriptive epidemiology of epilepsy-a review | Q37228015 | ||
| Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review | Q37398330 | ||
| Controlling cardiovascular diseases in low and middle income countries by placing proof in pragmatism | Q37405813 | ||
| Systematic review of the prevalence and incidence of Parkinson's disease in Asia | Q37583187 | ||
| The changing demographic pattern of multiple sclerosis epidemiology | Q37732614 | ||
| The changing and dynamic epidemiology of meningococcal disease | Q37969481 | ||
| Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review | Q38167677 | ||
| The increasing prevalence of multiple sclerosis in New Zealand | Q38189971 | ||
| The prevalence of Parkinson's disease: a systematic review and meta-analysis | Q38224356 | ||
| Stroke incidence, prevalence and mortality in women worldwide | Q38777534 | ||
| Stroke survivors in low- and middle-income countries: A meta-analysis of prevalence and secular trends | Q38809602 | ||
| The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis | Q38814892 | ||
| The Prevalence and Incidence of Dementia: a Systematic Review and Meta-analysis | Q38866368 | ||
| Global stroke statistics | Q38994221 | ||
| Prevalence of migraine, probable migraine and tension-type headache in the Croatian population | Q39935907 | ||
| Trends in tumors in the central nervous system in elderly in Denmark, 2008-2012. | Q40093333 | ||
| Disability weights for the Global Burden of Disease 2013 study | Q40422741 | ||
| Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011. | Q42204859 | ||
| Prevalence of migraine, tension-type headache, and other headaches in Hong Kong | Q43209387 | ||
| The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study | Q44761598 | ||
| Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). | Q44934166 | ||
| Incidence of ischaemic and haemorrhagic stroke and the association with smoking and smoking cessation: a 10-year multicentre prospective study in China. | Q44961051 | ||
| Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult t | Q45619007 | ||
| Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study | Q46147535 | ||
| WHO/WFN Survey of neurological services: a worldwide perspective | Q50112584 | ||
| Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. | Q50542571 | ||
| Increasing rates of dementia at time of declining mortality from stroke. | Q53277031 | ||
| Trends in new-onset epilepsy — the importance of comorbidities | Q58449714 | ||
| Prevalence of diphtheria and tetanus antibodies and circulation of Corynebacterium diphtheriae in São Paulo, Brazil | Q81376355 | ||
| P433 | issue | 11 | |
| P921 | main subject | Global Burden of Disease | Q499419 |
| P304 | page(s) | 877-897 | |
| P577 | publication date | 2017-09-15 | |
| P1433 | published in | Lancet Neurology | Q15755067 |
| P1476 | title | Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. | |
| P478 | volume | 16 |
| Q57808108 | 100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies |
| Q91208760 | A global perspective on the burden of multiple sclerosis |
| Q98196809 | A model PD registry for countries with limited resources |
| Q94585893 | A new lower limb portable exoskeleton for gait assistance in neurological patients: a proof of concept study |
| Q55122154 | Acupuncture as prophylaxis for chronic migraine: a protocol for a single-blinded, double-dummy randomised controlled trial. |
| Q93155727 | Adherence to Alternative Healthy Eating Index (AHEI-2010) is not associated with risk of stroke in Iranian adults: a case-control study |
| Q58704186 | Adherence to the dietary approaches to stop hypertension diet and risk of stroke: A meta-analysis of prospective studies |
| Q89870455 | Advancing the Use of Mobile Technologies in Clinical Trials: Recommendations from the Clinical Trials Transformation Initiative |
| Q92381661 | Age- and disease-specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease |
| Q55097512 | Air Pollution and Stroke. |
| Q47891782 | Alteration of gray matter texture features over the whole brain in medication-overuse headache using a 3-dimentional texture analysis |
| Q55499595 | Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates. |
| Q90723631 | An Evidence-Based Review of Fremanezumab for the Treatment of Migraine |
| Q92459506 | An international exchange observership at Yale University: A Ugandan physician experience |
| Q99237576 | An upper body garment with integrated sensors for people with neurological disorders - early development and evaluation |
| Q91717377 | Applying Deep Neural Network Analysis to High-Content Image-Based Assays |
| Q89134402 | Assessment of components included in published societal perspective or QALY outcome economic analyses for antiepileptic drug treatment in chronic epilepsy |
| Q55239700 | Association Between MicroRNAs Polymorphisms and Risk of Ischemic Stroke: A Meta-Analysis in Chinese Individuals. |
| Q89271248 | Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline: A Study Using Optical Coherence Tomography |
| Q55035770 | Association of epilepsy and asthma: a population-based retrospective cohort study. |
| Q57121937 | Associations of childhood socioeconomic status with mid-life and late-life cognition in Chinese middle-aged and older population based on a 5-year period cohort study |
| Q58113783 | Attitudes toward epilepsy among medical staffs in basic-level hospitals from southern China |
| Q90691805 | Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson's Disease |
| Q64135075 | Bacterial meningitis: more can be done |
| Q64100104 | Balance between innate versus adaptive immune system and the risk of dementia: a population-based cohort study |
| Q89895605 | Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System |
| Q55153386 | Burden of neurodevelopmental disorders in low and middle-income countries: A systematic review and meta-analysis. |
| Q57476572 | CNS infection and immune privilege |
| Q64108597 | Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination |
| Q93138854 | Cell therapy for Parkinson's disease is coming of age: current challenges and future prospects with a focus on immunomodulation |
| Q98210394 | Cerebrospinal fluid and blood levels of neurofilament light chain in Parkinson disease: A protocol for systematic review and meta-analysis |
| Q57651213 | Charakteristika und Dynamik der stationären Behandlung von Parkinson-Patienten in Deutschland |
| Q89185626 | Chronic Headache Due to Overuse of Analgesics and Anti-Migraine Agents |
| Q90019392 | Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing |
| Q91892869 | Cognitive and physical impairment and the risk of stroke - A prospective cohort study |
| Q55375108 | Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. |
| Q64120543 | Core curriculum guidelines for a required clinical neurology experience |
| Q58711914 | Costs, outcome and cost-effectiveness of neurocritical care: a multi-center observational study |
| Q89510771 | Deep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2-Hydroxyphenylbenzimidazole-based Scaffolds en Route to Donepezil-Like Compounds |
| Q90557021 | Delta opioid receptor agonists are effective for multiple types of headache disorders |
| Q88778345 | Design and Efficacy of Nanogels Formulations for Intranasal Administration |
| Q97518131 | Design and Operation of the Lombardy Parkinson's Disease Network |
| Q55262746 | Detection of Glycan Shedding in the Blood: New Class of Multiple Sclerosis Biomarkers? |
| Q52370391 | Developing DNA methylation-based diagnostic biomarkers. |
| Q92453263 | Development of an education and self-management intervention for chronic headache - CHESS trial (Chronic Headache Education and Self-management Study) |
| Q64119096 | Diagnosis and Management of Trochleodynia, Trochleitis, and Trochlear Headache |
| Q93079274 | Diagnostic Neuroimaging in Headache Patients: A Systematic Review and Meta-Analysis |
| Q91838120 | Diet-induced hypothalamic dysfunction and metabolic disease, and the therapeutic potential of polyphenols |
| Q93156909 | Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs |
| Q93046469 | Disease-Specific Mortality and Prevalence Trends in Korea, 2002-2015 |
| Q92478725 | Does the Disease of the Person Receiving Care Affect the Emotional State of Non-professional Caregivers? |
| Q92396128 | Drug-resistant epilepsy: From multiple hypotheses to an integral explanation using preclinical resources |
| Q64245495 | Dynamics of Parkinson's Disease Multimodal Complex Treatment in Germany from 2010⁻2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers |
| Q92188362 | Editorial: Clinical and Pathophysiological Peculiarities of Headache in Children and Adolescents |
| Q92349589 | Effect of Lipid-Testing Interval on Stoke Risk among Newly Diagnosed Dyslipidemia Patients Initiated on Statins |
| Q91777488 | Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON) |
| Q98775803 | Effects of medical comorbidities on the surgical outcomes of deep brain stimulation for Parkinson's disease: a retrospective, single-institution study |
| Q61816564 | Efficacy and safety of different drug monotherapies for tension-type headache in adults: study protocol for a Bayesian network meta-analysis |
| Q90264483 | Emerging Treatments in Episodic Migraine |
| Q90343793 | Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for migraine prevention |
| Q64948279 | Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial. |
| Q55347869 | Evaluation of gray matter perfusion in episodic migraine using voxel-wise comparison of 3D pseudo-continuous arterial spin labeling. |
| Q92514081 | Exploring the ameliorative role of α7 neuronal nicotinic acetylcholine receptor modulation in epilepsy and associated comorbidities in post-PTZ-kindled mice |
| Q100736987 | Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia |
| Q90087446 | From medications to surgery: advances in the treatment of motor complications in Parkinson's disease |
| Q92099816 | Fructus Viticis methanolic extract attenuates trigeminal hyperalgesia in migraine by regulating injury signal transmission |
| Q90608030 | Functional and self-care capacity of people with multiple sclerosis |
| Q57788277 | GBD 2016: still no improvement in the burden of migraine |
| Q93144395 | Genetic Analysis of a Large Family with Migraine, Vertigo, and Motion Sickness |
| Q91972929 | Ginsenoside-Rb1 for Ischemic Stroke: A Systematic Review and Meta-analysis of Preclinical Evidence and Possible Mechanisms |
| Q63740509 | Global Need for Physical Rehabilitation: Systematic Analysis from the Global Burden of Disease Study 2017 |
| Q92451797 | Global burden of neurological diseases highlights stroke |
| Q57058859 | Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 |
| Q63682872 | Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 |
| Q63352655 | Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 |
| Q64081729 | Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 |
| Q63681992 | Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 |
| Q62774346 | Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 |
| Q59131985 | Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 |
| Q100697461 | Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades |
| Q64102397 | Grand Total EEG Score Can Differentiate Parkinson's Disease From Parkinson-Related Disorders |
| Q57113261 | Gut-Brain Psychology: Rethinking Psychology From the Microbiota-Gut-Brain Axis |
| Q46550998 | Headache in Resource-Limited Settings |
| Q90480433 | Health-related stigma of noncommunicable neurological disease in rural adult populations: A scoping review |
| Q90269081 | Heme Oxygenase-1: Clinical Relevance in Ischemic Stroke |
| Q90361794 | High risk of anxiety and depression in caregivers of adult patients with epilepsy and its negative impact on patients' quality of life |
| Q49185851 | Hippocampal Neurodegenerative Pathology in Post-stroke Dementia Compared to Other Dementias and Aging Controls |
| Q92239438 | Immunological Aspects of Approved MS Therapeutics |
| Q93008901 | Impact of Evidence-Based Stroke Care on Patient Outcomes: A Multilevel Analysis of an International Study |
| Q91640421 | Impact of adherence to key performance indicators on mortality among patients managed for ischemic stroke |
| Q50100953 | Implementing Evidence-Based Practices for Acute Stroke Care in Low- and Middle-Income Countries |
| Q55361667 | In Hospital Stroke Mortality: Rates and Determinants in Southwestern Saudi Arabia. |
| Q57798606 | Increased CD74 binding and EAE treatment efficacy of a modified DRα1 molecular construct |
| Q89636322 | Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2) |
| Q64932789 | Intracranial artery stenosis magnetic resonance imaging aetiology and progression study: Rationale and design. |
| Q91675640 | Is Alzheimer's Disease Risk Modifiable? |
| Q52605692 | Is Migraine Primarily a Metaboloendocrine Disorder? |
| Q90095461 | Is cannabidiol a drug acting on unconventional targets to control drug-resistant epilepsy? |
| Q91794325 | Kolaviron protects against cognitive deficits and cortico-hippocampal perturbations associated with maternal deprivation in rats |
| Q92585255 | Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study |
| Q93051125 | Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer's Disease |
| Q92492633 | Long-Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52-Week Extension Trial |
| Q52589331 | Long-term risk of dementia among people with traumatic brain injury in Denmark: a population-based observational cohort study. |
| Q89749952 | Longitudinal patterns of cortical thinning in multiple sclerosis |
| Q100421324 | Looking at the burden of neurological disorders in Europe |
| Q92344434 | MS Energize: Field trial of an app for self-management of fatigue for people with multiple sclerosis |
| Q104617711 | Machine learning-based multimodal prediction of language outcomes in chronic aphasia |
| Q47180951 | Mapping of global scientific research in comorbidity and multimorbidity: A cross-sectional analysis |
| Q92567125 | Mass spectrometry-based proteomic techniques to identify cerebrospinal fluid biomarkers for diagnosing suspected central nervous system infections. A systematic review |
| Q89072455 | Mediterranean Diet in Preventing Neurodegenerative Diseases |
| Q92028537 | Metal Chelation Therapy and Parkinson's Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs |
| Q88012546 | Migraine |
| Q92347849 | Migraine: a major debilitating chronic non-communicable disease in Brazil, evidence from two national surveys |
| Q51744150 | Modulation of miRNA expression in aged rat hippocampus by buttermilk and krill oil. |
| Q55033375 | Morphometric changes over the whole brain in caffeine-containing combination-analgesic-overuse headache. |
| Q89963631 | Motor Imagery Training With Neurofeedback From the Frontal Pole Facilitated Sensorimotor Cortical Activity and Improved Hand Dexterity |
| Q64899271 | Multifaceted intervention to enhance cognition in older people at risk of cognitive decline: study protocol for the Protein Omega-3 and Vitamin D Exercise Research (PONDER) study. |
| Q51748526 | Multiple Sclerosis. |
| Q57159050 | Myofascial trigger points in migraine and tension-type headache |
| Q57166995 | Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer's Disease |
| Q92238062 | Network Meta-Analysis of Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine |
| Q92995093 | Network analysis of canine brain morphometry links tumour risk to oestrogen deficiency and accelerated brain ageing |
| Q91773901 | Neuroinflammation: friend and foe for ischemic stroke |
| Q90281909 | Neurological letter from Malawi |
| Q90042234 | Neurological update: dizziness |
| Q89449622 | Neurology outreach clinic for Huntington disease in Peru: Lessons for neurodegenerative diseases |
| Q47724356 | Neuropathology correlates of cognitive assessments |
| Q64969531 | Neuroprotective Effects and Hepatorenal Toxicity of Angong Niuhuang Wan Against Ischemia-Reperfusion Brain Injury in Rats. |
| Q56669735 | Neurosurgery and Sustainable Development Goals |
| Q64269971 | New Multitarget Hybrids Bearing Tacrine and Phenylbenzothiazole Motifs as Potential Drug Candidates for Alzheimer's Disease |
| Q88569634 | Nongenetic Optical Methods for Measuring and Modulating Neuronal Response |
| Q57465582 | Ocular motor cranial nerve palsy and increased risk of stroke in the general population |
| Q92741017 | Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease |
| Q57165507 | Paediatric migraine: evidence-based management and future directions |
| Q93154762 | Parents' and children's decision-making and experiences in pediatric epilepsy surgery |
| Q57168510 | Parkinson Matters |
| Q88310227 | Parkinson's disease, epileptic seizures, and sudden death: Three faces of the same coin |
| Q63888625 | Parkinsonian Tremor Detection from Subthalamic Nucleus Local Field Potentials for Closed-Loop Deep Brain Stimulation |
| Q64061800 | Peer support interventions for individuals with acquired brain injury, cerebral palsy, and spina bifida: a systematic review |
| Q90651779 | Phenotypic screening identifies a new oxazolone inhibitor of necroptosis and neuroinflammation |
| Q90101589 | Plasmon-Activated Water Reduces Amyloid Burden and Improves Memory in Animals with Alzheimer's Disease |
| Q95840679 | Possible Genetic Determinants of Response to Phenytoin in a Group of Colombian Patients With Epilepsy |
| Q89704901 | Premorbid instrumental activities of daily living predicts discharge home following stroke |
| Q90624853 | Presentation, etiology, and outcome of brain infections in an Indonesian hospital: A cohort study |
| Q89471313 | Prevalence of and characteristics associated with in-hospital mortality in a Ugandan neurology ward |
| Q96110703 | Prevalence of the major neurological disorders in a semi-urban community in northern Benin |
| Q91727961 | Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature |
| Q92133909 | Proactive and Integrated Management and Empowerment in Parkinson's Disease: Designing a New Model of Care |
| Q57057977 | Profile of Patients from a Neurology Registry in Resource-Poor Rural Northwest India |
| Q92303364 | Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine |
| Q92510163 | Re-thinking the Etiological Framework of Neurodegeneration |
| Q92140049 | Recommended Strategies for Physician Burnout, a Well-Recognized Escalating Global Crisis Among Neurologists |
| Q99565745 | Redox signaling and Alzheimer's disease: from pathomechanism insights to biomarker discovery and therapy strategy |
| Q64118653 | Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review |
| Q91793275 | Review on Cross Talk between Neurotransmitters and Neuroinflammation in Striatum and Cerebellum in the Mediation of Motor Behaviour |
| Q89905744 | Role of Region-Specific Brain Decellularized Extracellular Matrix on In Vitro Neuronal Maturation |
| Q92087985 | Role of data measurement characteristics in the accurate detection of Parkinson's disease symptoms using wearable sensors |
| Q55057482 | Rs4612666 Polymorphism of the NLRP3 Gene Is Associated with the Occurrence of Large Artery Atherosclerotic Ischemic Strokes and Microembolic Signals. |
| Q92712916 | Safety and Feasibility of Repeated Intrathecal Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells in Patients with Neurological Diseases |
| Q91716425 | Searching for Potential Lipid Biomarkers of Parkinson's Disease in Parkin-Mutant Human Skin Fibroblasts by HILIC-ESI-MS/MS: Preliminary Findings |
| Q91705285 | Seizure and epilepsy publication in nonneurology journals |
| Q92980030 | Sensory-motor and cardiorespiratory sensory rehabilitation associated with transcranial photobiomodulation in patients with central nervous system injury: Trial protocol for a single-center, randomized, double-blind, and controlled clinical trial |
| Q90697243 | Serum levels of Homocysteine, Vitamin B12 and Folate in Patients with Multiple Sclerosis: an Updated Meta-Analysis |
| Q92347862 | Shortcomings and missed potentials in the management of migraine patients - experiences from a specialized tertiary care center |
| Q92599162 | Spectrum of neurological disorders in neurology outpatients clinics in urban and rural Sindh, Pakistan: a cross sectional study |
| Q59360358 | Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa |
| Q48159193 | Study of Stroke Incidence in the Aseer Region, Southwestern Saudi Arabia. |
| Q100752639 | Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life |
| Q89477279 | Synthetic Chemical Trade as a Potential Driver of Global Health Disparities and Data Gaps on Synthetic Chemicals in Vulnerable Populations |
| Q58781288 | TRP Channels as Potential Targets for Sex-Related Differences in Migraine Pain |
| Q55084349 | Targeted CGRP Small Molecule Antagonists for Acute Migraine Therapy. |
| Q89530632 | Targeted next-generation sequencing identifies novel variants in candidate genes for Parkinson's disease in Black South African and Nigerian patients |
| Q89552026 | Targeting Macromolecules to CNS and Other Hard-to-Treat Organs Using Lectin-Mediated Delivery |
| Q89209485 | Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches |
| Q96289510 | Teaching the Emergency Neurological Life Support Course at Two Major Hospitals in Phnom Penh, Cambodia |
| Q62002053 | Teleneurology and mobile technologies: the future of neurological care |
| Q92053010 | The Anti-Inflammatory Effect of Sulforaphane in Mice with Experimental Autoimmune Encephalomyelitis |
| Q60950148 | The Emerging Evidence of the Parkinson Pandemic |
| Q64136787 | The Epidemiological Characteristics of Stroke in Hunan Province, China |
| Q58735688 | The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations |
| Q91801844 | The National Motorcycle Helmet Law at 2 Years: Review of Its Impact on the Epidemiology of Traumatic Brain Injury in a Major Government Hospital in Cambodia |
| Q53693063 | The Promise of Telemedicine for Movement Disorders: an Interdisciplinary Approach. |
| Q64245228 | The Role of Movement Analysis in Diagnosing and Monitoring Neurodegenerative Conditions: Insights from Gait and Postural Control |
| Q57175337 | The Therapeutic Potential of Metformin in Neurodegenerative Diseases |
| Q99410993 | The Universal Prescription for Parkinson's Disease: Exercise |
| Q67231682 | The World Bank & financing tuberculosis control, 1986-2017 |
| Q90573388 | The World Health Organization's Essential Diagnostics List: Diagnostics for neurologic disorders |
| Q49920091 | The advocacy role of the World Federation of Neurology |
| Q92744517 | The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population |
| Q57058856 | The burden of Parkinson's disease: a worldwide perspective |
| Q100421334 | The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017 |
| Q104479030 | The effect of weather, air pollution and seasonality on the number of patient visits for epileptic seizures: A population-based time-series study |
| Q49993779 | The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility |
| Q99585573 | The health burden of non-communicable neurological disorders in the USA between 1990 and 2017 |
| Q90413733 | The hidden costs of painful diabetic neuropathy revealed |
| Q61814693 | The impact of imperfect screening tools on measuring the prevalence of epilepsy and headaches in Burkina Faso |
| Q92654128 | The mitochondrial calcium uniporter: a new therapeutic target for Parkinson's disease-related cardiac dysfunctions? |
| Q99406315 | The predictive role of the neutrophil-lymphocyte ratio in the prognosis of adult patients with stroke |
| Q64064380 | The prevalence of MS in the United States: A population-based estimate using health claims data |
| Q52594717 | The primary prevention of epilepsy: A report of the Prevention Task Force of the International League Against Epilepsy. |
| Q97523249 | Therapeutic Implications of Altered Energy Metabolism in Migraine: A State-of-the-Art Review |
| Q92129055 | Thinking about dementia: is childhood too early? |
| Q55003682 | Towards earlier diagnosis and treatment of disorders of the brain. |
| Q90425683 | Toxoplasma gondii infection and risk of attention-deficit hyperactivity disorder: a systematic review and meta-analysis |
| Q64082178 | Traumatic brain injury induces long-lasting changes in immune and regenerative signaling |
| Q91593067 | Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability |
| Q91893519 | Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications |
| Q92608909 | Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study |
| Q55091400 | Use and overuse of triptans in Austria - a survey based on nationwide healthcare claims data. |
| Q93020470 | Validation of a patient satisfaction survey of the Teleneurology program in Chile |
| Q92832360 | Video consultations in medication overuse headache. A randomized controlled trial |
| Q49825852 | Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease. |
| Q58088043 | When Mom Has Migraine: An Observational Study of the Impact of Parental Migraine on Adolescent Children |
| Q90173483 | [Use of smartphone apps in secondary stroke prevention] |
| Q58568725 | point mutations and familial intracranial aneurysms |
Search more.